[Physiopathology of Raynaud phenomenon: current data].

No abstract is available for this paper.

• Publication year

  1997

• Venue

  La Revue de medecine interne

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 9365735
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Elevated plasma endothelin levels in systemic sclerosis

  2004cited by this paper
• Calcitonin gene-related peptide-like immunoreactivity in nerve fibers in the human skin

  2004cited by this paper
• Blockade of vasospastic attacks by alpha 2-adrenergic but not alpha 1-adrenergic antagonists in idiopathic Raynaud's disease.

  1995cited by this paper
• Plasma endothelin correlates with antiendothelial antibodies in patients with mixed connective tissue disease.

  1995cited by this paper
• Raynaud's phenomenon.

  1995cited by this paper
• A pathogenic role for endothelin in Raynaud's phenomenon?

  1994cited by this paper
• Circulating endothelin-1 levels in systemic sclerosis subsets--a marker of fibrosis or vascular dysfunction?

  1994cited by this paper
• Endothelin and collagen vascular disease: a review with special reference to Raynaud's phenomenon and systemic sclerosis.

  1994cited by this paper
• Increased endothelin-1 production in fibroblasts derived from patients with systemic sclerosis.

  1994cited by this paper
• Increased levels of endothelin-1 in bronchoalveolar lavage fluid from patients with systemic sclerosis contribute to fibroblast mitogenic activity in vitro.

  1994cited by this paper
• Increased plasma endothelin‐1 immunoreactive levels in vasculitis: a clue to the use of endothelin‐1 as a marker of vascular damage?

  1993cited by this paper
• Calcitonin gene-related peptide in treatment of severe peripheral vascular insufficiency in Raynaud's phenomenon.

  1993cited by this paper
• Characterization of endothelin-binding sites in human skin and their regulation in primary Raynaud's phenomenon and systemic sclerosis.

  1993cited by this paper
• Raynaud's phenomenon of the lung. A reality both in primary and secondary Raynaud syndrome.

  1992cited by this paper
• Systemic arterial vasospastic syndrome: familial occurrence with variant angina.

  1992cited by this paper
• Endothelin peptides: biological activities, cellular signalling and clinical significance.

  1992cited by this paper
• Macular capillary hemodynamic changes associated with Raynaud's phenomenon.

  1992cited by this paper
• Mechanism of Vascular Relaxation by the Calcitonin Gene‐Related Peptide a

  1992cited by this paper
• Polar secretion of endothelin-1 by cultured endothelial cells.

  1992cited by this paper
• Nitric oxide synthesis inhibitors attenuate calcitonin gene-related peptide endothelium-dependent vasorelaxation in rat aorta.

  1992cited by this paper
• Endothelin, vasoconstriction, and endothelial damage in Raynaud's phenomenon.

  1991cited by this paper
• Acquired factor VIII deficiency and polyradiculoneuropathy.

  1991cited by this paper
• Digital cutaneous vascular responses to histamine and neuropeptides in Raynaud's phenomenon.

  1991cited by this paper
• Image analysis quantification of peptide‐immunoreactive nerves in the skin of patients with Raynaud's phenomenon and systemic sclerosis

  1991cited by this paper
• Increased plasma endothelin levels in patients with Raynaud's phenomenon.

  1991cited by this paper
• The effects of cooling on human saphenous vein reactivity to adrenergic agonists.

  1990cited by this paper
• Deficiency of calcitonin gene-related peptide in Raynaud's phenomenon.

  1990cited by this paper
• Tissue distribution and half-life of 125I-endothelin in the rat: importance of pulmonary clearance.

  1990cited by this paper
• Serum endothelin-1 concentrations and cold provocation in primary Raynaud's phenomenon.

  1990cited by this paper
• International study of ketanserin in Raynaud's phenomenon.

  1989cited by this paper
• Increased alpha-adrenergic responsiveness in idiopathic Raynaud's disease.

  1989cited by this paper
• Adrenoceptors in Raynaud’s Disease

  1989cited by this paper
• Endothelium‐derived relaxing and contracting factors

  1989cited by this paper
• Role of alpha‐adrenoceptor subtypes mediating sympathetic vasoconstriction in human digits

  1988cited by this paper
• Serotonergic vasoconstriction in human fingers during reflex sympathetic response to cooling.

  1988cited by this paper
• Plasma free and intraplatelet serotonin in patients with Raynaud's phenomenon.

  1988cited by this paper
• alpha-Adrenoceptors and cold-induced vasoconstriction in human finger skin.

  1988cited by this paper
• Endothelium inhibits norepinephrine release from adrenergic nerves of rabbit carotid artery.

  1988cited by this paper
• How to classify Raynaud's phenomenon. Long-term follow-up study of 73 cases.

  1987cited by this paper
• Alpha 2-adrenergic receptor levels in obstructive and spastic Raynaud's syndrome.

  1987cited by this paper
• The anti‐aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide

  1987cited by this paper
• Human postjunctional alpha-1 and alpha-2 adrenoceptors: differential distribution in arteries of the limbs.

  1987cited by this paper
• Occurrence and distribution of neuropeptides in the human skin. An immunocytochemical and immunochemical study on normal skin and blister fluid from inflamed skin.

  1987cited by this paper
• Beta-blockers: a new therapeutic approach to Raynaud's disease.

  1987cited by this paper
• Selective antagonism of S2-serotonergic receptors relieves but does not prevent cold induced vasoconstriction in primary Raynaud's phenomenon.

  1986cited by this paper
• Prevalence of Raynaud phenomenon in the general population. A preliminary study by questionnaire.

  1986cited by this paper
• Agonist interactions at hepatic alpha 1- and beta-adrenergic receptors: affinity-state regulation by guanine nucleotides and temperature.

  1986cited by this paper
• Plasma beta-thromboglobulin in the differential diagnosis of Raynaud's phenomenon.

  1985cited by this paper
• Sympathetic outflow to the hand in patients with Raynaud's phenomenon.

  1985cited by this paper
• Cooling and alpha 1- and alpha 2-adrenergic responses in cutaneous veins: role of receptor reserve.

  1985cited by this paper
• Modulation of postjunctional alpha-adrenergic responsiveness by local changes in temperature.

  1985cited by this paper
• Altered regulator mechanisms of presynaptic adrenergic nerve: a new physiopathological hypothesis in Raynaud's disease.

  1984cited by this paper
• Alpha-adrenergic receptors in platelets from patients with Raynaud's syndrome.

  1983cited by this paper
• Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing

  1983cited by this paper
• Increased factor VIII/von Willebrand factor antigen and von Willebrand factor activity in scleroderma and in Raynaud's phenomenon.

  1981cited by this paper
• Cold hypersensitivity after sympathectomy for Raynaud's disease.

  1980cited by this paper
• Instantaneous changes of alpha-adrenoceptor affinity caused by moderate cooling in canine cutaneous veins.

  1978cited by this paper
• Prevalence of primary Raynaud phenomena in young females.

  1978cited by this paper
• Studies of endogenous catecholamines in patients with Raynaud's phenomenon secondary to progressive systemic sclerosis (scleroderma).

  1972cited by this paper
• A quantitative study of the response to cold of the circulation through the fingers of normal subjects.

  1950cited by this paper

• Spinal Cord Stimulation for Raynaud's Syndrome: Long‐Term Alleviation of Bilateral Pain With a Single Cervical Lead

  2011cites this paper
• Putative mechanisms behind effects of spinal cord stimulation on vascular diseases: a review of experimental studies.

  2008cites this paper
• 5-hydroxytryptamine receptors in the human cardiovascular system.

  2006cites this paper
• [Helicobacter pylori prevalence in Raynaud's disease].

  2006cites this paper
• Exaggerated local hand sympathetic but not renin-angiotensin system activation in patients with primary Raynaud's phenomenon.

  2006cites this paper
• Low level laser therapy in primary Raynaud's phenomenon--results of a placebo controlled, double blind intervention study.

  2004cites this paper
• [Management of Raynaud's phenomenon].

  2001cites this paper